ARTICLE |
Correspondence to: Daryn Kenny, Bayer Diagnostics, PO Box 2466, Berkeley, CA 94702-0466.
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In situ hybridization (ISH) methods for detection of nucleic acid sequences have proved especially powerful for revealing genetic markers and gene expression in a morphological context. Although target and signal amplification technologies have enabled researchers to detect relatively low-abundance molecules in cell extracts, the sensitive detection of nucleic acid sequences in tissue specimens has proved more challenging. We recently reported the development of a branched DNA (bDNA) ISH method for detection of DNA and mRNA in whole cells. Based on bDNA signal amplification technology, bDNA ISH is highly sensitive and can detect one or two copies of DNA per cell. In this study we evaluated bDNA ISH for detection of nucleic acid sequences in tissue specimens. Using normal and human papillomavirus (HPV)-infected cervical biopsy specimens, we explored the cell type-specific distribution of HPV DNA and mRNA by bDNA ISH. We found that bDNA ISH allowed rapid, sensitive detection of nucleic acids with high specificity while preserving tissue morphology. As an adjunct to conventional histopathology, bDNA ISH may improve diagnostic accuracy and prognosis for viral and neoplastic diseases.
(J Histochem Cytochem 50:12191227, 2002)
Key Words: branched DNA (bDNA), cervical intraepithelial, neoplasia (CIN) biopsies, human papillomavirus (HPV), in situ hybridization
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
CONVENTIONAL HISTOPATHOLOGY is traditionally the first line of investigation for understanding disease. Because certain pathomorphological features are often associated with viral and neoplastic diseases, histological examination of tissues can identify diagnostic criteria for disease, determine the extent of disease progression, and provide insight for prognosis. For example, hepatic inflammation in liver biopsies distinguishes chronic hepatitis C from autoimmune chronic hepatitis (
Among the methods used for detection of molecular markers, in situ hybridization (ISH) offers the unique advantage of visualizing and even quantifying clinically relevant molecules in a morphological context (
We recently reported the development of a branched DNA (bDNA) ISH method for detection of DNA and mRNA in whole cells (
In this study we evaluated the bDNA ISH method for detection of nucleic acid sequences in clinical tissue specimens. Using normal and HPV-infected cervical biopsy specimens as a model system, we explored the cell type-specific distribution of HPV DNA and mRNA by bDNA ISH with oligonucleotide probes designed for HPV-16 and HPV-18 E6/E7 gene sequences. We assessed the distribution of HPV DNA and mRNA among the various cell types present in cervical intraepithelial neoplasias (CIN), explored the cell type-specificity of HPV localization by comparing epithelial regions with and without dysplasia, and demonstrated the specificity of bDNA ISH by comparing HPV detection in sections from HPV-16- and HPV-18-infected CIN II and normal cervical biopsies.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Specimens
Formalin-fixed, paraffin-embedded uterine cervix Leep cone biopsy specimens were obtained from Clinomics Laboratories (Frederick, MD) with Internal Review Board approval. Clinical diagnosis was provided in surgical pathology reports that specified moderate cervical dysplasia (CIN II). The catalog numbers of three HPV-positive and three normal specimens were 00B01-624, 00B01-627, 00B01-625, and H-1188-88, 00B01-631, 00B01-632, respectively. Koilocytes and dysplastic cells were identified using the Bethesda System and as described in diagnostic cytology texts (
Oligonucleotide Probes
Target-specific oligonucleotide probes for HPV-16 and HPV-18 E6/E7 and for GAPDH were designed using ProbeDesigner Software (Bayer Diagnostics; Berkeley, CA) as described previously (
Pretreatment of Tissue Sections
Formalin-fixed paraffin sections of cervical tissue were dewaxed and rehydrated with standard histological methods using xylenes and graded ethanol series. For DNA detection, tissue was digested first with 100 µg/ml RNase in RNase buffer (0.5 M NaCl, 10 mM Tris, pH 9.0, 1 mM EDTA) at 37C for 1 hr and then with 12 µg/ml proteinase K in PBS (0.01 M phosphate buffer, pH 7.5) at 37C for 10 min. Immersion in Antigen Unmasking Solution (DAKO; Carpinteria, CA) for 540 min at 92C was substituted for proteinase K digestions in some experiments for HPV detection in basal cells and for HPV detection in tissue sections that exhibited higher background staining. After digestion, proteinase K was inactivated by postfixation in 4% paraformaldehyde in PBS at 4C for 10 min. Tissue sections were washed several times in PBS and then acetylated in 1 M triethanolamine and 0.1 M acetic anhydride. Tissue sections were then dehydrated in a graded ethanol series, denatured at 92C for 5 min in 80% formamide in 2 x SSC (1 x SSC is 0.15 M NaCl, 0.015 M Na-citrate) in a humidity chamber (Hybaid Omnislide instrument; Phoenix Research Products, Hayward, CA), followed by immersion in cold 70% ethanol and dehydration. For detection of mRNA, the procedure was the same except that there was no RNase digestion or high-temperature denaturation.
bDNA ISH
After pretreatment (described above), tissue sections were incubated with hyb 1 buffer (50% formamide, 0.2% casein, 3 x SSC, 10% dextran sulfate, 100 µg/ml salmon sperm DNA) at 40C for 30 min. HPV-specific target probes were then added in 80 µl of fresh hyb 1 buffer at a concentration of 10 fmol/µl to each slide and coverslips were placed over slides. Hybridization was carried out in a humidified slide chamber on a slide warmer at 40C for 13 hr. After hybridization with target probes, tissue sections were washed in a graded series of SSC buffers from 2 x SSC to 0.1 x SSC for a total of 15 min of wash time. Coverslip-covered tissue sections were incubated with preamplifier probes at a concentration of 1 fmol/µl in hyb 2 buffer (5 x SSC, 10% dextran sulfate, 0.1% sodium dodecyl sulfate, 1 mM ZnCl2, 10 mM MgCl2) at 55C for 25 min, and washed in three changes of 0.1 x SSC for 5 min. Tissue sections were then incubated with amplifier probes at a concentration of 1 fmol/µl in hyb 2 buffer at 55C for 25 min and washed in three changes of 0.1 x SSC for 5 min. Finally, tissue sections were incubated with AP-conjugated label probe at a concentration of 1 fmol/µl in 80 µl hyb 2 buffer at 55C for 15 min, washed in three changes of 0.1 x SSC for 5 min, and washed once in 100 mM Tris-(hydroxymethyl)aminomethane, pH 8.0, 0.1% BRIJ-35, 1 mM ZnCl2, 10 mM MgCl2. Fast Red staining buffer (K0597; DAKO) containing 5 µm levamisole was prepared immediately before application to tissue sections and color was developed for 410 min. Nuclei were counterstained for 40 sec with Gills 1 hematoxylin (American Histology Reagent; Modesto, CA), and coverslips were placed on slides for microscopy. Digital images were captured using a Nicon Eclipse microscope, Polaroid digital camera and software, Dell computer with Microsoft Windows 2000 operating system, and combined into figures using Adobe Photoshop 5.5.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Specific Detection of HPV E6/E7 mRNA in CIN II Lesions
A total of 50 serial sections of CIN II tissue from cervical Leep cone biopsy number 627 were analyzed in 12 consecutive experiments using bDNA ISH. A montage of several photographs depicting the distribution of HPV-16 E6/E7 mRNA in CIN II tissue sections is shown in Fig 1. As shown in Fig 1A, hybridization with HPV-16 E6/E7 target probes in tissue sections prepared for mRNA detection consistently yielded signal in the top one third to one half of the squamous epithelia in areas of cells with koilocytic changes, indicating that HPV-16 E6/E7 mRNA was present in these cells. HPV-16 E6/E7 expression was associated with regions of cells that exhibited several of the cytopathic changes that characterize high-grade squamous intraepithelial lesions (HSIL) and/or HPV infection, including high nuclear/cytoplasmic ratios, atypical nuclei with a heterogeneous size and shape, binucleation, and perinuclear clear zones (
|
Spurious staining of the mucus-rich columnar epithelia associated with follicles and other tissue regions was observed in some specimens more than others, regardless of HPV-16 E6/E7 mRNA detection. In most specimens this nonspecific staining was reduced significantly by the addition of acetylation and/or antigen retrieval pretreatment. Another kind of spurious staining was observed in which random deposition of the Fast Red reporter substrate occurred over a few stromal cells (right side of Fig 1A) and over a few cells at lower left of Fig 1D. This staining pattern was not reproduced on adjacent sections and was therefore clearly different from cell type- and probe-specific staining observed in koilocytes that was reproducible on adjacent sections throughout the biopsy.
The highly localized substrate deposition and low background staining of bDNA ISH allowed identification of distinct HPV-16 E6/E7-expressing cells within a tightly packed heterogeneous epithelium containing many cells without detectable HPV-16 E6/E7 mRNA. Fig 1B is a higher-magnification view of the boxed area in Fig 1A. In this region there was a mixture of stained and unstained cells, and several of the cells that stained positive for HPV-16 E6/E7 mRNA also featured cytopathic changes such as multiple nuclei or koilocytic atypia. The subcellular distribution of HPV-16 E6/E7 mRNA was predominantly localized to plasma membrane-associated cytosol and in the nuclei of a few cells but was excluded from the clear perinuclear portion of the cytoplasm. Because the AP-conjugated reporter probe was linked to the target nucleic acid, the AP staining reaction resulted in the precipitation of reporter substrate Fast Red in specific cells without diffusion into adjacent cells. Therefore, individual koilocytes that expressed HPV-16 E6/E7 mRNA were clearly distinguished from adjacent cells that were negative for HPV-16 E6/E7 mRNA.
As a control, an adjacent section prepared for mRNA detection was hybridized with GAPDH-specific target probes. As shown in Fig 1E, this yielded signal that was distributed in cells throughout the squamous epithelium uniformly between koilocytes and dysplastic regions, and also in endocervical columnar epithelium and stromal cells. Detection of GAPDH transcripts throughout the squamous epithelia is consistent with the well-known ubiquitous expression pattern of this housekeeping gene and confirms that this tissue contained RNA available for hybridization to probes.
Comparative Distribution of HPV-16 E6/E7 mRNA and DNA
Adjacent sections of CIN II tissue were analyzed to determine the relative distribution of HPV-16 E6/E7 mRNA and DNA. As shown in Fig 1C, hybridization with HPV-16 E6/E7 target probes in adjacent tissue sections prepared for DNA detection reproducibly yielded signal that was localized primarily to cell nuclei, indicating that HPV-16 E6/E7 DNA was present in regions of cells that expressed HPV-16 E6/E7 mRNA. An adjacent section hybridized with HPV-18 E6/E7 target probes yielded no signal above background (Fig 1D), indicating that the signal detected with HPV-16 E6/E7 target probes was specific. The distribution of HPV-16 E6/E7 DNA in squamous epithelia was generally more extensive than that of HPV-16 E6/E7 mRNA throughout the multiple tissue biopsies examined. For example, HPV-16 E6/E7 DNA was detected in individual basal cells and parabasal cells in addition to areas of cells with koilocytic changes. HPV-16 E6/E7 DNA also was detected in a subset of cells within dysplastic regions. Although a number of cells in dysplastic regions exhibited very strong staining for HPV-16 E6/E7 DNA, staining was not detected in a number of neighboring cells in the dysplastic region. In contrast, throughout the CIN II biopsies examined HPV-16 E6/E7 mRNA was not typically detected in basal cells, proliferating squamous cell precursors, columnar epithelium of the endocervix, or underlying stromal cells, and was not necessarily detected in regions of epithelial dysplasia.
Detection of HPV-16 E6/E7 DNA in Epithelia with Abnormal Squamous Cell Maturation
To determine if the distribution of HPV-16 E6/E7 DNA was associated with regions exhibiting histopathic changes associated with viral infection or neoplasia, 50 sections of each of the HPV-positive biopsies were extensively examined using bDNA ISH. Fig 2A and Fig 2B show two adjacent epithelial regions from the same tissue section of specimen 624. Fig 2A shows a region of normal squamous cell maturation in which HPV-16 E6/E7 DNA was not detected. By contrast, Fig 2B shows a nearby region of the same epithelium that exhibited highly abnormal squamous cell maturation, with moderate dysplasia marked by overgrowth of basal cells and mixing of undifferentiated cells, differentiated squamous cells, koilocytes, and dysplastic cells. In this region, HPV-16 E6/E7 DNA was detected in nuclei of cells exhibiting koilocytic changes and in some cells close to the basement membrane. However, similar to specimen 627, HPV-16 E6/E7 DNA was predominantly detected in regions of cells with koilocytic changes and was not necessarily detected in areas of dysplasia.
|
Detection of HPV-16 E6/E7 DNA in Basal Cells of CIN II Lesions
With the bDNA ISH method it was also possible to identify individual basal cells that contained HPV-16 E6/E7 DNA. As shown in Fig 2C, the relatively weak signal for HPV-16 E6/E7 DNA detection in basal cells and parabasal cells near the basement membrane was more clearly distinguished from background by incorporating an antigen-unmasking pretreatment step in the bDNA ISH protocol. Although HPV-16 E6/E7 DNA was detected in some basal cells throughout specimen 624, it was not detected in basal cells of other CIN II specimens examined. In addition to HPV-16 E6/E7 DNA detection in basal cells, specimen 624 also exhibited a greater number of HPV-infected cells and a greater preponderance of signal in these cells.
Genotype-specific Detection of HPV-16 and HPV-18 E6/E7 DNA in CIN II Lesions
Tissue sections from multiple CIN II biopsies were analyzed to compare the distribution of HPV-16 and HPV-18 E6/E7 DNA. Fig 3 shows sections from two CIN II cervical tissues that were analyzed with bDNA ISH. HPV-16 E6/E7 DNA was detected in CIN II specimen 624 (Fig 3A) but not in CIN II specimen 625 (Fig 3C). By comparison, HPV-18 E6/E7 DNA was detected in CIN II specimen 625 (Fig 3D) but not in CIN II specimen 624 (Fig 3B). These results demonstrate that the detection of HPV DNA in CIN II lesions using bDNA ISH was genotype-specific.
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In our previous study we demonstrated single-copy gene detection sensitivity for bDNA ISH using cell lines (
In overcoming the challenges for localization of nucleic acid sequences in clinical tissue sections, bDNA ISH offers many advantages over target amplification methods such as PCR ISH. For example, the histopathological features of formalin-fixed, paraffin-embedded tissue sections are well preserved with bDNA ISH, in part because bDNA signal amplification does not require repeated heat cycling (
Differences in technology distinguish bDNA from other signal amplification systems such as tyramide signal amplification (TSA) applied to ISH. TSA and bDNA ISH have similar sensitivities in cell lines and are effective in detection of target sequences in tissues (
Although this study focused primarily on the efficacy of bDNA ISH for detection of HPV in cervical tissue specimens, bDNA ISH may be applicable to genotype- and cell type-specific detection of high-risk HPV genotypes in other tissues with HPV-associated cancers, such as head and neck (
Studies using sensitive techniques such as bDNA ISH to further investigate the topographical distribution of HPV and neoplasia in cervical biopsies might offer unique insight into the disease process. Although the potential clinical role of HPV testing is controversial (
In summary, bDNA ISH is a reproducible, sensitive, specific, and precise method for localizing nucleic acid sequences in clinical tissue sections with exquisite preservation of tissue morphology. As an adjunct to conventional histopathology, bDNA ISH may contribute to the understanding, diagnosis, and prognosis of disease.
![]() |
Acknowledgments |
---|
We thank Linda Wuestehube for critical reading of the manuscript and editorial expertise.
Received for publication November 30, 2001; accepted March 20, 2002.
![]() |
Literature Cited |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Arends MJ, Buckley CH, Wells M (1998) Aetiology, pathogenesis, and pathology of cervical neoplasia. J Clin Pathol 51:96-103[Abstract]
Bach N, Thung SN, Schaffner F (1992) The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 15:572-577[Medline]
Bayer EA, Wilchek M (1978) The avidin-biotin complex as a tool in molecular biology. Trends Biochem Sci 3:N237-239
Bishop JW, Marshall CJ, Bentz JS (2000) New technologies in gynecologic cytology. J Reprod Med 45:701-719[Medline]
Bovicelli A, Bristow RE, Montz FJ (2000) HPV testing: where are we now? Anticancer Res 20:4673-4680[Medline]
Bushnell S, Budde J, Catino T, Cole J, Derti A, Kelso R, Collins ML, Molino G et al. (1999) ProbeDesigner: for the design of probesets for branched DNA (bDNA) signal amplification assays. Bioinformatics 15:348-355
Cheng YW, Chiou HL, Sheu GT, Hsieh LL, Chen JT, Chen CY, Su JM et al. (2001) The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res 61:2799-2803
Collins ML, Irvine B, Tyner D, Fine E, Zayati C, Chang C, Horn T et al. (1997) A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml. Nucleic Acids Res 25:2979-2984
Daniel RW, Ahdieh L, Hayden D, CuUvin S, Shah KV (2000) Intra-laboratory reproducibility of human papillomavirus identification in cervical specimens by a polymerase chain reaction-based assay. J Clin Virol 19:187-193[Medline]
Dreau D, Culberson C, Wyatt S, Holder WD, Jr (2000) Human papilloma virus in melanoma biopsy specimens and its relation to melanoma progression. Ann Surg 231:664-671[Medline]
Femino AM, Fay FS, Fogarty K, Singer RH (1998) Visualization of single RNA transcripts in situ. Science 280:585-590
Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML et al. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:709-720
Ishak KG, Anthony PP, Sobin LH (1998) Histological Typing of Tumors of the Liver. New York, Springer-Verlag
Kaufman RH, Adam E (1999) Is human papillomavirus testing of value in clinical practice? Am J Obstet Gynecol 180:1049-1053[Medline]
Kerstens HM, Poddighe PJ, Hanselaar AG (1995) A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine. J Histochem Cytochem 43:347-352
Knowles DM, Chadburn A (1992) Lymphadenopathy and lymphoid neoplasma associated with the acquired immune deficiency syndrome (AIDS). In Knowles DM, ed. Neoplastic Hematopathology. Baltimore, Williams & Wilkins, 773-783
Koss LG (1992) Diagnostic Cytology and its Histopathologic Basis. Philadelphia, JB Lippincott
Kurman RJ, Solomon D (1994) The Bethesda System for Reporting Cervical/Vaginal Cytological Diagnoses. New York, Springer-Verlag
Manos MM, Kinney WK, Hurley LB, Sherman ME, ShiehNgai J, Kurman RJ, Ransley JE et al. (1999) Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 281:1605-1610
Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Moller B et al. (2001) Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344:1125-1131
Nuovo GJ, MacConnell P, Forde A, Delvenne P (1991) Detection of human papillomavirus DNA in formalin-fixed tissues by in situ hybridization after amplification by polymerase chain reaction. Am J Pathol 139:847-854[Abstract]
Player AN, Shen LP, Kenny D, Antao VP, Kolberg JA (2001) Single copy gene detection using branched DNA (bDNA) in situ hybridization. J Histochem Cytochem 49:603-612
Plummer TB, Sperry AC, Xu HS, Lloyd RV (1998) In situ hybridization detection of low copy nucleic acid sequences using catalyzed reporter deposition and its usefulness in clinical human papillomavirus typing. Diagn Mol Pathol 7:76-84[Medline]
Ross JS, Fletcher JA (1999) HER-2/neu (c-erb-B2) gene and protein in breast cancer. Am J Clin Pathol 112:S53-67[Medline]
Stoler MH, Broker TR (1986) In situ hybridization detection of human papillomavirus DNAs and messenger RNAs in genital condylomas and a cervical carcinoma. Hum Pathol 17:1250-1258[Medline]
Unger ER (2000) In situ diagnosis of human papillomaviruses. Clin Lab Med 20:289-301[Medline]
van de Corput MP, Dirks RW, van Gijlswijk RP, van Binnendijk E, Hattinger CM, de Paus RA, Landegent JE et al. (1998) Sensitive mRNA detection by fluorescence in situ hybridization using horseradish peroxidase-labeled oligodeoxynucleotides and tyramide signal amplification. J Histochem Cytochem 46:1249-1259
Wagner D, Ikenberg H, Boehm N, Gissmann L (1984) Identification of human papillomavirus in cervical swabs by deoxyribonucleic acid in situ hybridization. Obstet Gynecol 64:767-772[Abstract]
Wiedorn KH, Kuhl H, Galle J, Caselitz J, Vollmer E (1999) Comparison of in-situ hybridization, direct and indirect in-situ PCR as well as tyramide signal amplification for the detection of HPV. Histochem Cell Biol 111:89-95[Medline]
Wilchek M, Bayer EA (1988) The avidin-biotin complex in bioanalytical applications. Anal Biochem 171:1-32[Medline]
zur Hausen H (1996) Papillomavirus infectionsa major cause of human cancers. Biochim Biophys Acta 1288:F55-78[Medline]